Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people notice they feel warmer than usual after starting Mounjaro (tirzepatide), particularly in the first few weeks of treatment or after a dose increase. This warmth is generally tied to the way tirzepatide changes how your body manages energy and blood flow, and for most people it settles on its own. Mounjaro is a prescription-only medicine; a clinical prescriber determines whether it is suitable for you before treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The hours following a Mounjaro injection can bring a noticeable flush or a sense of internal warmth, especially around the face, neck and chest. This is largely a result of the way tirzepatide acts as a dual GIP and GLP-1 receptor agonist: it activates pathways that increase metabolic rate and alter the way your body distributes heat. Think of it as your system recalibrating. For people who notice this effect most sharply on Monday mornings after an over-the-weekend injection, the timing can feel inconvenient — but that pattern itself is informative, linking the sensation clearly to the dose rather than to illness or the environment.
The NHS tirzepatide medicines page lists flushing among the recognised side effects of the medicine, alongside the more widely discussed gastrointestinal symptoms. Warmth and sweating are typically mild, transient and more noticeable at the start of treatment or on moving to a higher dose. If you are curious about the broader range of physical sensations people experience at the beginning of treatment, our overview of feeling unwell on Mounjaro covers the wider picture.
Most heat sensations on Mounjaro are benign. They come on gradually, affect the skin surface or produce a feeling of inner warmth, and pass within an hour or two. Night sweats that wake you intermittently in the first couple of weeks after a dose increase also fall within the expected range.
There are signals, though, that shift this from a routine side effect into something worth acting on promptly. A sudden, intense flush accompanied by a racing heart, hives, swelling of the lips or throat, or shortness of breath could indicate an allergic or hypersensitivity reaction, seek same-day medical help. Severe stomach pain that extends towards your back, particularly when paired with sweating and feeling generally unwell, is a warning sign for acute pancreatitis, which the MHRA highlighted as a known but infrequent risk in a Drug Safety Update issued in January 2026. Do not wait to see if it eases; call 111 or attend your nearest urgent care centre. If you are also experiencing light-headedness alongside the heat, our page on dizziness on Mounjaro explains when that combination matters most.
Plenty of people find feeling hot on Mounjaro manageable with a few straightforward adjustments. Staying well hydrated is the most consistently useful one: tirzepatide reduces appetite, which can mean inadvertently drinking less, and mild dehydration amplifies the sense of overheating. Cool, loose clothing on injection days, keeping a room aired out overnight, and avoiding alcohol around the time of your weekly dose all tend to help.
Caffeine and spicy food can both heighten flushing in people who are already warm, so reducing either temporarily on injection day is worth trying. Some people find moving their injection to the evening means the sharpest warmth happens during sleep and causes less disruption to the day. Your prescriber can advise whether timing adjustments suit your individual plan; the Mounjaro treatment information page is a good starting point for context before that conversation.
It is also worth noting that feeling hot sometimes travels with other sensations, a feeling of heaviness or low energy, for instance. Our page on weakness during Mounjaro treatment addresses that pairing directly. On the opposite end of the spectrum, a small number of people on tirzepatide actually feel unusually cold; there is a separate explanation for that on our feeling cold on Mounjaro page, and it relates to the same metabolic shift from a different direction.
Tirzepatide's effects reach further than appetite alone. There is emerging interest in how GLP-1 and GIP pathways interact with the body's stress-hormone systems, and our page on whether Mounjaro affects cortisol summarises what is currently known. The short version: the metabolic changes driving weight loss (accelerated fat use, shifting insulin sensitivity, altered energy expenditure) generate heat as a by-product. This is thermogenesis, and it is part of why treatment works. Feeling warmer during active weight loss phases is therefore not incidental; it reflects the medicine doing something.
None of this changes the practical calculus: if warmth is persistent, severe, or stopping you sleeping properly, raise it with your clinical team. It is one of the more common questions our prescribers receive, and it is always worth a conversation rather than a guess. You can find current private treatment options through our weight-loss treatments page, and if cost is a consideration before starting, the Mounjaro pricing guide sets out what is typically involved.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.